Global X Genomics & Biotechnology ETF
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Global X Genomics & Biotechnology ETF's balance sheet done over the years? Its assets were worth $130,203,000 last year. 37% of Global X Genomics & Biotechnology ETF’s total assets is currently financed by debt. Its liabilities reached the amount of $47,589,000.
Debt to Assets
| 2011 | 130203000 | 47.58M | 36.55% |
|---|
GNOM Balance Sheet (2011 – 2011)
| 2011 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 77.07M |
Short term investments | 7.14M |
Net receivables | 6.48M |
Inventory | 4.12M |
Other current assets | 341K |
Total current assets | 95.16M |
Non-current assets: | |
Property, Plant and Equipment | 33.59M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 1.44M |
Total non-current assets | 35.03M |
Total assets | 130.20M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 10.02M |
Short term debt | 7.09M |
Total current liabilities | 27.88M |
| Non-current liabilities: | |
Long term debt | 16.16M |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 19.70M |
Total liabilities | 47.58M |
| Data source |